Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 Trials

Overview of attention for article published in European Urology Oncology, November 2024

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 5 X users

Readers on

mendeley: 5 Mendeley

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 2,002 followers.

Publication Snapshot: Combined analysis of NRG-RTOG 9202, 9413, and 9902 - PubMed: https://t.co/0vwTaqE2aO https://t.co/4L5CTc9ZNm

RT @Davicioni: Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncolo… https:/…

Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncolo… https://t.co/nY1M65vbgk @krishnan_patel @NRGonc

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.